The Whipple procedure, which removes part of the pancreas, intestine and gallbladder, is the standard for pancreatic cancer.

An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new study.

Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

Pancreatic cancer kills 50,000 people each year, according to the National Cancer Institute, and there are few effective ...

Pancreatic cancer is one of the most lethal malignancies, with nearly 50,000 deaths annually in the United States, according ...

Researchers at UC San Diego have discovered that the enzyme MICAL2 accelerates tumor growth in pancreatic cancer by ...

The disease is rarely found in time for lifesaving treatment, and kills about half a million people annually; here is what to ...

The FDA approved several drugs in December for the treatment of diseases including pancreatic adenocarcinoma, lung cancer, ...

It kills about half a million people every year. Pancreatic cancer can often be halted, but it's rarely detected in time. The ...

Gedatolisib is under clinical development by Celcuity and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I drugs for Pancreatic Cancer have a 74% phase transition success ...

In its pursuit of a cancer drug for pancreatic cancer and possibly ovarian cancer, Amplia has history on its side.